Complete Congenital Heart Block in a Newborn Associated with Maternal Systemic Lupus Erythematosus: A Case Report

Authors

  • Mahmoud A. Kiblawi RAK Medical College, RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.
  • Alina Naeem RAK Medical College, RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.
  • Elham A. Al Attrash RAK Medical College, RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.
  • Subhranshu Kar RAK Medical College, RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.
  • B. K. M. Goud RAK Medical College, RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.

DOI:

https://doi.org/10.5195/ijms.2013.220

Keywords:

Congenital Heart Block, Systemic Lupus Erythematosus, Bradycardia, SS-A Antibodies

Abstract

Background: Complete Congenital Heart Block (CCHB) is a rare disease of the newborn that carries significant morbidity and mortality. CCHB can be diagnosed early or late in life. In newborns, it is usually associated with maternal autoantibodies or a congenital cardiac structural abnormality. The most common presentation of CCHB is bradycardia that can be diagnosed by an electrocardiogram.

Results: This is a case report of a male infant born to a mother with an autoimmune disease, Systemic Lupus Erythematosus (SLE), who was found to have third degree heart block at birth.

Conclusion: Early diagnosis and prompt management of the case is important for a better prog­nosis and prevention of associated complications. Neonates with CCHB should be managed at a tertiary care center and the only definite treatment is insertion of a pacemaker. Moreover, prenatal diagnosis and specific obstetric counseling of pregnant women with SLE along with careful monitoring with serial ultrasonography and echocardiography are of paramount importance in prevention of the disease in subsequent offspring.

Metrics

Metrics Loading ...

Author Biography

Mahmoud A. Kiblawi, RAK Medical College, RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.

Mahmoud Ahmed Kiblawi, recently graduated from a MBBS program at RAK Medical and Health Sciences University, Ras Al Khaimah, UAE, where he was honored thrice for best academic performance.

References

1. Michaëlsson M, Engle MA. Congenital complete heart block: An internatio¬nal study of the natural history. Cardiovasc Clin. 1972;4(3):85-101.
2. Hon KL, Leung AK. Neonatal lupus Erythematosus. Autoimmune Dis. 2012;2012:301274.
3. Admani S, Krakowski AC. Neonatal Lupus Erythematosus Presenting as Atypical Targetoid-like Lesions Involving Genitals and Soles of Feet Following Brief Sun Exposure. J Clin Aesthet Dermatol. 2013;6(5):19-23.
4. Hardy JD, Solomon S., Banwell GS, Beach R, Wright V, Howard FM. Congeni¬tal complete heart block in the newborn associated with maternal systemic lupus erythematosus and other connective tissue disorders. Arch Dis Child¬hood. 1979;54(1):7-13.
5. Winkler RB, Nora AH, Nora JJ. Familial congenital complete heart block and maternal systemic lupus erythematosis. Circulation. 1977;56(6):1103-7.
6. McCredie M, Celermajer J, Sholler G, Kelly D, Chivers T, Wang Y, et al. A case-control study of congenital heart block: association with maternal anti-bodies to Ro(SS-A) and La(SS-B). Br J Rheumatol. 1990;29(1):10-4.
7. Brucato A. Prevention of congenital heart block in children of SSA-positive mothers. Rheumatology (Oxford). 2008;47(Suppl3):iii35-7.
8. Moutasim K, Shirlaw P, Escudier M, Poate T. Congenital heart block associa¬ted with Sjögren syndrome: case report. Int Arch Med. 2009;2(1):21.
9. Elish D, Silverberg NB. Neonatal lupus erythematosus. Cutis. 2006;77(2):82-6.
10. Boros CA, Spence D, Blaser S, Silverman ED. Hydrocephalus and ma¬crocephaly: new manifestations of neonatal lupus erythematosus. Arthritis Rheum. 2007;57(2):261-6.
11. Izmirly PM, Saxena A, Kim MY, Wang D, Sahl SK, Llanos C, et al. Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. Circulation. 2011;124(18):1927-35.
12. Morquio, L. Sur une maladie infantile et familiale characterisée par des modifications permanentes du pouls, des attaques syncopales et epileptifor-me et la mort subite. Arch Méd d’Enfants. 1901;4:467.
13. Yater WM. Congenital heart block; review of the Literature; Report of a case with incomplete heterotaxy; the electrocardiogram in dextrocardia. Am J Dis Child 1929;38(1):112-36.
14. Mondal T, Dubey NK, Jajoo D, Dutta A, Sharma D. Congenital complete heart block. Indian Pediatr. 1995;32(11):1221-4.
15. Lazzerini PE, Capecchi PL, Guideri F, Acampa M, Galeazzi M, Laghi Pasini F. Connective tissue diseases and cardiac rhythm disorders: an overview. Autoimmun Rev. 2006;5(5):306-13.
16. Veille JC, Covitz W. Fetal cardiovascular hemodynamics in the presen¬ce of complete atrioventricular block. Am J Obstet Gynecol. 1994;170(5 Pt 1):1258-62.
17. Dipti TR, Azam MS, Sattar MH, Rahman SA. Detection of anti-nuclear anti¬body by immunofluorescence assay and enzyme immunoassay in childhood systemic lupus erythematosus: experience from Bangladesh. Int J Rheum Dis. 2012;15(1):121-5.
18. Gordon PA. Congenital heart block: clinical features and therapeutic approaches. Lupus. 2007;16(8):642-6.
19. Camm AJ, Bexton RS. Congenital complete heart block. Eur Heart J. 1984;5 (Suppl A):115-7
20. Moak JP, Barron KS, Hougen TJ, Wiles HB, Balajj S, Sreeram N, et al. Con¬genital heart: development of late-onset cardiomyopathy, a previously under appreciated sequela. J Am Coll Cardiol. 2001;37(1):238-242.
21. Edwards CS, Mootoo R, Bhanji A. High grade heart block in association with SLE. Ann Rheum Dis. 2004;63(5):606.
22. Chronister CS. Congenital complete atrioventricular block in a young man: a case study. Crit Care Nurse. 2009;29(5):45-56.
23. Ambrosi A, Wahren-Herlenius M. Congenital heart block: evidence for a pathogenic role of maternal autoantibodies. Arthritis Res Ther. 2012;14(2):208.
24. Jaeggi ET, Hamilton RM, Silverman ED, Zamora SA, Hornberger LK. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution’s experience of 30 years. J Am Coll Cardiol. 2002;39(1):130-7.
25. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, et al. Autoim¬mune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol. 1998;31(7):1658-66.
26. Guettrot-Imbert G, Cohen L, Fermont L, Villain E, Frances C, Thiebau¬georges O, et al. A new presentation of neonatal lupus: 5 cases of isolated mild endocardial fibroelastosis associated with maternal Anti-SSA/Ro and Anti-SSB/La antibodies. J Rheumatol. 2011;38(2):378-86.
27. Breur JM, Visser GH, Kruize AA, Stoutenbeek P, Meijboom EJ. Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature. Ultrasound Obstet Gynecol. 2004;24(4):467.
28. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/Ame¬rican Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Car¬diac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117(21):e350-408.
29. Kaszala K, Huizar JF, Ellenbogen KA. Contemporary pacemakers: what the primary care physician needs to know. Mayo Clin Proc. 2008;83(10):1170-86.

Downloads

Published

2013-12-31

How to Cite

Kiblawi, M. A., Naeem, A., Al Attrash, E. A., Kar, S., & Goud, B. K. M. (2013). Complete Congenital Heart Block in a Newborn Associated with Maternal Systemic Lupus Erythematosus: A Case Report. International Journal of Medical Students, 1(3), 128–131. https://doi.org/10.5195/ijms.2013.220

Issue

Vol. 1 No. 3 (2013)

Section

Case Report

Categories

License

  1. The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
  2. Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
  3. The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
    1. Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
    2. The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
    3. Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
    4. Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
    5. The Author represents and warrants that:
      1. the Work is the Author’s original work;
      2. the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
      3. the Work is not pending review or under consideration by another publisher;
      4. the Work has not previously been published;
      5. the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
      6. the Work contains no libel, invasion of privacy, or other unlawful matter.
    6. The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.

Enforcement of copyright

The IJMS takes the protection of copyright very seriously.

If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.

If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org

 

Infringing material

If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org